STERIS plc (STE): Rasio rega marang prakiraan pendapatan
STERIS plc demonstrates exceptional stability due to its dominance in the sterilization niche and stringent FDA barriers. The brand's impeccable authority in medicine and the balance between system sales and consumables guarantee resilience. The company's forward P/S dynamics confirm the asset's fundamental strength, where the 2.70 mark serves as a key metric for assessing fair value and protecting capital from overheating.
Rincian analitis perusahaan STERIS Group (STE)
- rega saham lan target rega konsensus:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Rasio Total Utang marang Ekuitas STERIS plc|STE - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang ekuitas STERIS plc|STE - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku STERIS Group|STE - Gunggunge utang jangka dawa|Kewajiban jangka cendhak perusahaan STERIS|Rasio cepet steris.com
- rincian asil keuangan lan kelipatan valuasi:
STE - Penghasilan resik perusahaan|Bathi sing dikarepake STERIS plc|STE - Nilai perusahaan marang bathi resik|Pangali Forward P/E STERIS Corporation|STE - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan STERIS Group|STE - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan STERIS|STE - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan steris.com|STE - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep STERIS plc
- rincian pendapatan lan dodolan:
Analisis komprehensif perusahaan:STE (STERIS)
The forward P/S ratio determines current market capitalization relative to projected revenue for the following year, measuring the premium for future growth. By analyzing the forward P/S trend, an investor assesses whether the stock price is justified through the lens of revenue generation efficiency. For STERIS plc (STE), a high valuation is supported by predictable demand for sterilization systems and consumables, which ensure a stable operating cash flow.
Analisis perusahaan pesaing
Intuitive - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Danaher Corporation DHR|BDX - Rasio rega marang prakiraan pendapatan|West Pharma Corp (WST) - Multiplikator forward rega marang pendapatan|BAX: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep masimo.com (MASI)|Rasio rega marang prakiraan pendapatan Stevanato Group|Kapitalisasi marang prakiraan pendapatan TFX (Teleflex Inc.)|Multiplikator forward rega marang pendapatan MMSI (Merit Medical Systems Inc)|Rasio rega marang pendapatan sing dikarepake NVST|Rasio rega marang prakiraan pendapatan ICU Medical, Inc. ICUI|Rasio kapitalisasi marang dodolan sing dikarepake dentsplysirona.com (XRAY)|LMAT - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake AtriCure Inc ATRC|STAA (STAAR Surgical Corp) - Multiplikator forward rega marang pendapatan|NAGE: Rasio rega marang pendapatan sing dikarepake|ZIMV (ZimVie Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep angiodynamics.com ANGO|Rasio rega marang prakiraan pendapatan Cerus (CERS)|TKNO (Alpha Teknova) - Rega forward marang dodolan|Multiplikator Forward P/S MGRM (Monogram Technologies Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Sharps Technology Inc (STSS)|INFU - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake utahmed.com UTMD|KRMD (korumedical.com) - Multiplikator forward rega marang pendapatan|Nyxoah SA - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Microbot Medical Inc|Pro-Dex Inc. - Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Zentek Ltd. (ZTEK)|Rasio rega marang prakiraan pendapatan ELUT (elutia.com)|Multiplikator Forward P/S MLSS (Milestone Scientific Inc.)|NXGL - Multiplikator forward rega marang pendapatan|RVP - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake harvardbioscience.com HBIO|FEMY (Femasys Inc.) - Multiplikator forward rega marang pendapatan|MHUA: Rasio rega marang pendapatan sing dikarepake|POAI (Predictive Oncology Inc) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Callan JMB Corp CJMB|Rasio rega marang prakiraan pendapatan Atrion Corp (ATRI)|Multiplikator forward rega marang pendapatan NeuroMetrix Corporation NURO
